| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Marc D Kozin is Director at UFPT and has filed Form 4s across 3 companies. Marc D Kozin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.9M at current prices.
The biggest single holding is UFPT (~$5.9M) as Director. The UFPT filings lean toward selling, a net 28,340 shares.
Marc D Kozin has 50 Form 4 filings on record from March 2015 to August 2026, across 3 companies: Director at UFP Technologies (UFPT), 2015–2026; Director at Tempest Therapeutics (TPST), 2015–2018; Director at Salarius Pharmaceuticals (DCOY), 2015–2018.
The 83 reported transactions were 28 stock awards, 18 option or other derivative awards, 15 open-market sales and 15 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 4 purchases worth about $241K and 4 sales worth about $3.2M.
The largest open-market purchase was 3,000 shares of TPST at an average $28.45 on April 8, 2015, about $85K.
The largest open-market sale was 7,000 shares of UFPT at an average $304.50 on August 25, 2026, about $2.1M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | UFPT Ufp Technologies, Inc. | Director | Sell | 7,000 | $304.50 | $2,131,475.00 | -24.9% | - | - | |
| Mar 8, 2021 | UFPT Ufp Technologies Inc | Director | Sell | 10,000 | $54.10 | $540,956.62 | -24.2% | - | - | |
| Mar 10, 2020 | UFPT Ufp Technologies Inc | Director | Sell | 4,933 | $46.06 | $227,223.93 | -10.8% | - | - | |
| Sep 11, 2019 | UFPT Ufp Technologies Inc | Director | Sell | 6,407 | $39.92 | $255,770.80 | -17.9% | - | - | |
| Nov 19, 2015 | DCOY Salarius Pharmaceuticals, Inc. | Director | Buy | 4,500 | $11.38 | $51,219.00 | New | - | - | |
| Oct 5, 2015 | TPST Tempest Therapeutics, Inc. | Director | Buy | 4,800 | $10.79 | $51,792.00 | +30.5% | - | - | |
| Sep 8, 2015 | TPST Tempest Therapeutics, Inc. | Director | Buy | 3,000 | $17.60 | $52,800.00 | +25.8% | - | - | |
| Apr 8, 2015 | TPST Tempest Therapeutics, Inc. | Director | Buy | 3,000 | $28.45 | $85,350.00 | +36.2% | - | - |